ZIMVV ZIMVIE INC

ZimVie to Present at the UBS Global Healthcare Conference

ZimVie to Present at the UBS Global Healthcare Conference

PALM BEACH GARDENS, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming UBS Global Healthcare Conference. Management will be presenting on Tuesday, November 12, 2024 at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time.

A live webcast of the event, as well as an archived recording will be available on ZimVie’s investor website at .

About ZimVie

ZimVie is a global life sciences leader in the dental market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. From its headquarters in Palm Beach Gardens, Florida, and additional facilities around the globe, ZimVie works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including trusted dental implants, biomaterials, and digital workflow solutions. As a worldwide leader in this space, ZimVie is committed to advancing clinical science and technology foundational to restoring daily life. For more information about ZimVie, please visit us at . Follow @ZimVie on , , , or .

Media Contact Information:

ZimVie

Grace Flowers • (561) 319-6130

Investor Contact Information:

Gilmartin Group LLC

Marissa Bych •



EN
29/10/2024

Underlying

ZIMVVZIMVIE INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ZIMVIE INC

 PRESS RELEASE
Free
ZIMVV ZIMVIE INC

ZimVie Reports Fourth Quarter and Full Year 2024 Financial Results

ZimVie Reports Fourth Quarter and Full Year 2024 Financial Results FY2024 Third Party Net Sales from Continuing Operations of $449.7 millionFY2024 Net Loss from Continuing Operations of $(33.8) million; Net Loss margin of (7.5%) FY2024 Adjusted EBITDA[1] from Continuing Operations of $60.0 million; Adjusted EBITDA[1] margin of 13.3%FY2024 GAAP diluted EPS from Continuing Operations of $(1.23) and adjusted diluted EPS[1] of $0.62 PALM BEACH GARDENS, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today reported financ...

February 26, 2025 1 EN
 PRESS RELEASE
Free
ZIMVV ZIMVIE INC

ZimVie to Report Fourth Quarter and Full-Year 2024 Financial Results o...

ZimVie to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025 PALM BEACH GARDENS, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the fourth quarter and full-year 2024 after market close on Wednesday, February 26, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Those interested in listening to the conference call should . Participants are encouraged to register more than 15 minute...

February 12, 2025 1 EN
 PRESS RELEASE
Free
ZIMVV ZIMVIE INC

ZimVie Announces Publication of a Study Supporting the Benefits of Its...

ZimVie Announces Publication of a Study Supporting the Benefits of Its Implant Surface Technologies Data confirms ZimVie implants meet critical roughness criteria advantageous for long-term peri-implant health PALM BEACH GARDENS, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced the publication of a detailed scientific study demonstrating the surface texture of ZimVie’s premium implants may help to lower the risk of peri-implant infections when compared to other commercially available implants....

January 30, 2025 1 EN
 PRESS RELEASE
Free
ZIMVV ZIMVIE INC

ZimVie Reports Third Quarter 2024 Financial Results

ZimVie Reports Third Quarter 2024 Financial Results Third Party Net Sales from Continuing Operations of $103.2 millionNet Loss from Continuing Operations of $(3.0) million; Net Loss margin of (3.0%) Adjusted EBITDA[1] from Continuing Operations of $13.1 million; Adjusted EBITDA[1] margin of 12.7%GAAP diluted EPS from Continuing Operations of $(0.11) and adjusted diluted EPS of $0.12 PALM BEACH GARDENS, Fla., Oct. 30, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today reported financial results for the quarter ended September 30,...

October 30, 2024 1 EN
 PRESS RELEASE
Free
ZIMVV ZIMVIE INC

ZimVie to Present at the UBS Global Healthcare Conference

ZimVie to Present at the UBS Global Healthcare Conference PALM BEACH GARDENS, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming UBS Global Healthcare Conference. Management will be presenting on Tuesday, November 12, 2024 at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time. A live webcast of the event, as well as an archived recording will be available on ZimVie’s investor website at . About ZimVieZimVie is a global life sciences leader in the dental market t...

October 29, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch